Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QuikClot Sport Silver is a hemostatic medical device developed by Z-Medica Corporation (now a subsidiary of Teleflex) for the rapid control of moderate to severe external hemorrhage. The product consists of a porous mesh bag containing beads of the mineral zeolite, which acts as a molecular sieve to rapidly absorb water from the blood. This dehydration process concentrates platelets and endogenous coagulation factors at the wound site, significantly accelerating the natural clotting cascade to form a stable clot, typically in under five minutes. This specific 'Silver' formulation incorporates ionic silver, which provides broad-spectrum antimicrobial and antifungal properties to prevent infection in contaminated wounds or when immediate medical care is unavailable. While widely utilized by emergency responders and military personnel, zeolite-based QuikClot products have largely been superseded in professional settings by kaolin-based formulations to eliminate the exothermic reaction associated with zeolite hydration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QuikClot Sport Silver.